GGrantIndex
← Leaderboards

Steven Joffe

Dana-Farber Cancer Institute

$10,832,464
Attributed
$13,311,816
Total exposure
9
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $5.2M · FY200525
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,311,816 · 9

By mechanism

U01$4,958,704 · 1
T32$3,055,467 · 1
R01$3,011,159 · 3
P30$938,640 · 1
K01$720,907 · 1
R21$406,032 · 1

Top collaborators

Most similar at Dana-Farber Cancer Institute

Same institution · by research overlap

Others in their field

Top investigators on “Ethics

Research focus

EthicsGeneticClinical ResearchMalignant NeoplasmsResearch PersonnelEnsureSurveysGenomicsBasePoliciesParticipantReportingMemberAffectDesignClinical TrialsTraining ProgramsCharacteristicsFamilyAdverse EventPost-Doctoral TrainingProtocols DocumentationDatabasesBelief

Grant awards (34)

Penn Postdoctoral Training Program in the Ethical, Legal and Social Implications of Genetics and Genomics$482,073
T32 · FY2025 · HG · contact PI
Ethical, Legal, Social Implication Core$220,907
U54 · FY2025 · AG · contact PI
Penn Postdoctoral Training Program in the Ethical, Legal and Social Implications of Genetics and Genomics$433,850
T32 · FY2024 · HG · contact PI
Penn Postdoctoral Training Program in the Ethical, Legal and Social Implications of Genetics and Genomics$266,262
T32 · FY2023 · HG · contact PI
Penn Postdoctoral Training Program in the Ethical, Legal and Social Implications of Genetics and Genomics$460,337
T32 · FY2022 · HG · contact PI
Randomized trial of universal vs. guideline-directed germline testing among young adults with cancer$143,595
U01 · FY2022 · CA
The Penn Postdoctoral Training Program in the Ethical, Legal and Social Implications of Genetics and Genomics$254,890
T32 · FY2021 · HG · contact PI
The Penn Postdoctoral Training Program in the Ethical, Legal and Social Implications of Genetics and Genomics$379,312
T32 · FY2020 · HG · contact PI
Randomized trial of universal vs. guideline-directed germline testing among young adults with cancer$4,815,109
U01 · FY2019 · CA
The Penn Postdoctoral Training Program in the Ethical, Legal and Social Implications of Genetics and Genomics$352,040
T32 · FY2019 · HG · contact PI
The Penn Postdoctoral Training Program in the Ethical, Legal and Social Implications of Genetics and Genomics$259,535
T32 · FY2018 · HG · contact PI
The Penn Postdoctoral Training Program in the Ethical, Legal and Social Implications of Genetics and Genomics$167,168
T32 · FY2017 · HG · contact PI
Survey and Data Management$192,485
P30 · FY2016 · CA · contact PI
Survey and Data Management$192,659
P30 · FY2015 · CA · contact PI
Accountability and the Role of the Principal Investigator in Multicenter Trials$260,343
R01 · FY2014 · CA · contact PI
Survey and Data Management$183,450
P30 · FY2014 · CA · contact PI
Survey and Data Management$177,395
P30 · FY2013 · CA · contact PI
Survey and Data Management$192,651
P30 · FY2012 · CA · contact PI
Accountability and the Role of the Principal Investigator in Multicenter Trials$112,410
R01 · FY2012 · CA · contact PI
Returning Individual Genetic Results to Participants in Cohort Studies$413,842
R01 · FY2011 · HG · contact PI
Accountability and the Role of the Principal Investigator in Multicenter Trials$385,711
R01 · FY2011 · CA · contact PI
Returning Individual Genetic Results to Participants in Cohort Studies$58,000
R01 · FY2011 · HG · contact PI
Returning Individual Genetic Results to Participants in Cohort Studies$477,040
R01 · FY2010 · HG · contact PI
Accountability and the Role of the Principal Investigator in Multicenter Trials$333,210
R01 · FY2010 · CA · contact PI
Capacity of Children and Teens to Decide About Cancer Trials$185,040
R21 · FY2010 · CA · contact PI
Returning Individual Genetic Results to Participants in Cohort Studies$467,825
R01 · FY2009 · HG · contact PI
Capacity of Children and Teens to Decide About Cancer Trials$220,992
R21 · FY2009 · CA · contact PI
Compliance with adverse event reporting requirements in cancer clinical trials$247,777
R01 · FY2007 · CA · contact PI
Compliance with adverse event reporting requirements in cancer clinical trials$255,001
R01 · FY2006 · CA · contact PI
Ethical Challenges in Cancer Clinical Research$157,437
K01 · FY2006 · CA · contact PI
Ethical Challenges in Cancer Clinical Research$157,437
K01 · FY2005 · CA
Ethical Challenges in Cancer Clinical Research$135,380
K01 · FY2004 · CA
Ethical Challenges in Cancer Clinical Research$135,344
K01 · FY2003 · CA
Ethical Challenges in Cancer Clinical Research$135,309
K01 · FY2002 · CA